ABAC Therapeutics' Series A Round

ABAC Therapeutics raised a round of funding on February 15, 2018.

ABAC Therapeutics is utilizing its discovery platform PasNas to identify novel pathogen-specific antibiotics designed to selectively kill multi-drug resistant bacteria. This approach allows the pursui…

Articles about ABAC Therapeutics' Series A Round: